ESNT.L

Essentra Plc
Essentra plc - Transaction in Own Shares
24th October 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3818J
Essentra plc
24 October 2024
 

24 October 2024

ESSENTRA PLC

Transaction in Own Shares

Essentra plc ("Essentra", or the "Company") announces that on 23 October 2024 it purchased the following number of its ordinary shares of 25 pence each in the Company ("Ordinary Shares") from Peel Hunt LLP as part of the buyback programme announced on 29 March 2023 (the "Buyback Programme").

ESSENTRA ORD 25P


Date of purchase:

23/10/2024

Aggregate number of Ordinary 25p Shares purchased:

50,000

Lowest price paid per share (GBp):

152.0000

Highest price paid per share (GBp):

152.0000

Volume weighted average price paid per share (GBp):

152.0000

Broker

PEEL HUNT

 

Essentra intends to cancel the purchased Ordinary Shares.

Following the settlement of the above purchases and cancellation, Essentra will have 287,093,244

Ordinary Shares of 25 pence each in issue (excluding 3,627,057 Ordinary Shares of 25 pence each held in treasury).

 

Upon cancellation, the figure 287,093,244 will represent the total number of voting rights in Essentra and can be used by shareholders once the shares have been cancelled as the denominator for the calculations by which they can determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.      

 

Trading Venue

Volume-weighted average price paid per share (Gbp)

Aggregated number of shares purchased

Aquis (AQXE)

-

-

BATS (BATE)

-

-

Chi-X (CHIX)

-

-

Turquoise (TRQX)

-

-

London Stock Exchange (XLON)

152.0000

50,000

Total

152.0000

50,000

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Peel Hunt LLP as part of the Buyback Programme.

This announcement is made in accordance with the requirements of Listing Rule 12.4.6.

 

For further enquiries, please contact:

Essentra plc

Emma Reid, Company Secretary

Tel: +44 (0)1908 359100

Schedule of Purchases - Individual Transactions

Number of shares purchased

Transaction price (Gbp)

Market / Sytematic Internaliser

Time of transaction

Trade ID

17000

152

XLON

09:22:15

00168115816TRLO0

33000

152

XLON

08:56:13

00168113517TRLO0

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFZMZGRFMGDZM]]>
TwitterFacebookLinkedIn